ASLAN Pharmaceuticals Limited (ASLN) Misses Q4 EPS by 48c
Tweet
Share
E-mailGet Alerts ASLN Hot Sheet
Join SI Premium – FREE
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) reported Q4 EPS of ($0.66), $0.48 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on ASLAN Pharmaceuticals Limited (ASLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
